Samsung C&T (028260) Q1 2026 earnings summary

Executive summary

• Consolidated sales reached KRW 10,466 bn in 1Q26, up KRW 729 bn year-over-year but down KRW 366 bn sequentially from 4Q25.

• Net profit was KRW 1,086 bn, a KRW 149 bn increase year-over-year but a KRW 472 bn decrease from the previous quarter.

• Operating profit stood at KRW 720 bn, nearly flat year-over-year and down KRW 102 bn sequentially.

Financial highlights

• Gross profit rose to KRW 1,869 bn, up KRW 116 bn year-over-year.

• Operating margin was 6.9%, down 0.5 percentage points year-over-year and 0.7 points sequentially; adjusted margin excluding one-off costs was 7.8%.

• Non-operating profit surged to KRW 526 bn, up KRW 306 bn sequentially and KRW 90 bn year-over-year.

• Total assets increased to KRW 105,087 bn, up KRW 42,629 bn year-over-year.

• Net cash position improved to KRW 2,714 bn, up KRW 1,721 bn year-over-year.

Outlook and guidance

• Engineering & Construction expects sales and operating profit to rise in 2Q26, driven by high-tech project momentum.

• Trading & Investment anticipates a partial QoQ decline in 2Q26 but targets full-year sales growth via market and product diversification.

• Fashion aims for continued YoY growth in 2Q and full year, focusing on product competitiveness and new brands.

• Biologics projects full-year sales growth of 15–20% YoY, with profitability stable; Epis Holdings expects over 10% sales growth.